Lixte Biotechnology Shares Down on Plans for Nomad Transportable Power Deal, Name Change

Dow Jones
06/13
 

By Josh Beckerman

 

Shares of Lixte Biotechnology Holdings declined after it announced plans to buy battery energy company Nomad Transportable Power Systems and change Lixte's name to Nomad Power Solutions.

The stock was down 12% to $6.41 in Friday afternoon trading. Shares are up 63% this year.

Cancer-drug developer Lixte said June 1 that it would transform into an AI energy infrastructure equipment and services business, and seek a strategic acquisition partner for its pharmaceutical and medical technology operations.

Lixte didn't disclose a deal price for Nomad. The company said Nomad's revenue rose about 175% in 2025. Lixte said Nomad's mobile utility-grade battery energy storage systems have a structural permitting and deployment advantage, offering an alternative to permanent BESS projects that "routinely face development timelines of two to five years or longer."

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

June 12, 2026 13:48 ET (17:48 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10